PMC:7441788 / 4436-4627 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":28,"end":37},"obj":"Disease"},{"id":"T46","span":{"begin":89,"end":97},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T35","span":{"begin":71,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T36","span":{"begin":98,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T37","span":{"begin":133,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T38","span":{"begin":142,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39","span":{"begin":161,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":13,"end":15},"obj":"Chemical"},{"id":"T54","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"T55","span":{"begin":130,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T33","span":{"begin":13,"end":15},"obj":"Chemical"},{"id":"T34","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"T35","span":{"begin":130,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T45","span":{"begin":89,"end":97},"obj":"Species"}],"attributes":[{"id":"A45","pred":"ncbi_taxonomy_id","subj":"T45","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T38","span":{"begin":44,"end":116},"obj":"Sentence"},{"id":"T39","span":{"begin":117,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"197","span":{"begin":10,"end":12},"obj":"Gene"},{"id":"203","span":{"begin":89,"end":97},"obj":"Species"},{"id":"206","span":{"begin":13,"end":15},"obj":"Chemical"},{"id":"207","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"208","span":{"begin":112,"end":115},"obj":"Chemical"},{"id":"209","span":{"begin":130,"end":132},"obj":"Chemical"},{"id":"211","span":{"begin":28,"end":37},"obj":"Disease"}],"attributes":[{"id":"A197","pred":"pubann:denotes","subj":"197","obj":"Gene:56925"},{"id":"A203","pred":"pubann:denotes","subj":"203","obj":"Tax:694009"},{"id":"A206","pred":"pubann:denotes","subj":"206","obj":"MESH:D002738"},{"id":"A207","pred":"pubann:denotes","subj":"207","obj":"MESH:D002738"},{"id":"A208","pred":"pubann:denotes","subj":"208","obj":"MESH:D006886"},{"id":"A209","pred":"pubann:denotes","subj":"209","obj":"MESH:D002738"},{"id":"A211","pred":"pubann:denotes","subj":"211","obj":"MESH:D007239"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T33","span":{"begin":28,"end":37},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T39","span":{"begin":28,"end":37},"obj":"Disease"},{"id":"T40","span":{"begin":89,"end":97},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-PubTator","denotations":[{"id":"197","span":{"begin":10,"end":12},"obj":"Gene"},{"id":"203","span":{"begin":89,"end":97},"obj":"Species"},{"id":"206","span":{"begin":13,"end":15},"obj":"Chemical"},{"id":"207","span":{"begin":68,"end":70},"obj":"Chemical"},{"id":"208","span":{"begin":112,"end":115},"obj":"Chemical"},{"id":"209","span":{"begin":130,"end":132},"obj":"Chemical"},{"id":"211","span":{"begin":28,"end":37},"obj":"Disease"}],"attributes":[{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"Gene:56925"},{"id":"A203","pred":"tao:has_database_id","subj":"203","obj":"Tax:694009"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"MESH:D002738"},{"id":"A207","pred":"tao:has_database_id","subj":"207","obj":"MESH:D002738"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"MESH:D006886"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:D002738"},{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":44,"end":116},"obj":"Sentence"},{"id":"T39","span":{"begin":117,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}

{"project":"2_test","denotations":[{"id":"32496926-15351731-132195659","span":{"begin":39,"end":41},"obj":"15351731"}],"text":"99% at 16 μM CQ 3 days post-infection [12]. The data indicates that CQ has stronger anti-SARS-CoV activity than HCQ. In addition, CQ has both a prophylactic and a therapeutic advantage. Vince"}